Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Terminated (1)

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Cxlusa (1)

Joint Authority for Paijat-Hame Social and Health Care (1)

Sociedad de Lucha Contra el Cancer del Ecuador (1)

Collaborator

Tampere University (1)

University of Jyvaskyla (1)

Intervention

5-aminolevulinic acid (5-ala) gliolan® (1)

aminolevulinic acid nano emulsion (1)

cxlo corneal strengthening solution and uva illumination device (1)

fluorescence-guided surgery using 5-aminolevulinic acid (5-ala) (1)

hexylaminolevulinate cream (1)

methylaminolevulinate cream (1)

Study Documents

Intervention Type

drug (2)

combination product (1)

procedure (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational (1)

photosensitizing agents

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

5-Aminolevulinic Acid Gliolan®: Usage Increase Proposal for

Not yet recruiting

High Grade Glioma
+10 more

5-Aminolevulinic Acid (5-ALA) Gliolan®
Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)

Guayaquil, Guayas, Ecuador

Sociedad de Lucha Contra el Cáncer

Apr 28, 2023

Keratoconus, Corneal Diseases, Eye Diseases Trial in United States (CXLO Corneal Strengthening Solution and UVA Illumination

Terminated

Has Results

Keratoconus
+3 more

CXLO Corneal Strengthening Solution and UVA Illumination Device

Scottsdale, Arizona
+8 more

Dec 15, 2021

Tumors, Basal Cell, Carcinoma, Basal Cell, Photochemotherapy Trial in Lahti (Hexylaminolevulinate cream, Aminolevulinic Acid

Active, not recruiting

Neoplasms, Basal Cell
+3 more

Hexylaminolevulinate cream
+2 more

Lahti, Finland

Joint Authority for Päijät-Häme Social and Health Care

Mar 26, 2019